These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31532463)

  • 21. Opioid Prescription Patterns Among US Gastroenterologists From 2013 to 2017.
    Chen FW; LeBrett WG; Yang L; Chang L
    Gastroenterology; 2020 Feb; 158(3):776-779.e2. PubMed ID: 31647903
    [No Abstract]   [Full Text] [Related]  

  • 22. Survey of Primary Care and Mental Health Prescribers' Perspectives on Reducing Opioid and Benzodiazepine Co-Prescribing Among Veterans.
    Hawkins EJ; Malte CA; Hagedorn HJ; Berger D; Frank A; Lott A; Achtmeyer CE; Mariano AJ; Saxon AJ
    Pain Med; 2017 Mar; 18(3):454-467. PubMed ID: 27558857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring the Effectiveness of Benzodiazepine Prescriptions Control in Community Setting Using Prescription Drug Monitoring Program (PDMP).
    Agrawal R; Verma S; Halappanavar M
    Community Ment Health J; 2021 Jul; 57(5):920-925. PubMed ID: 32666418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015.
    Guy GP; Zhang K; Halpin J; Sargent W
    Am J Prev Med; 2019 Nov; 57(5):629-636. PubMed ID: 31564606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
    Manders L; Abd-Elsayed A
    Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid Coprescribing with Sedatives after Implant-Based Breast Reconstruction.
    Santosa KB; Wang CS; Hu HM; Mullen CR; Brummett CM; Englesbe MJ; Bicket MC; Myers PL; Waljee JF
    Plast Reconstr Surg; 2022 Dec; 150(6):1224e-1235e. PubMed ID: 36103669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017.
    Jones CM; Compton W; Vythilingam M; Giroir B
    JAMA; 2019 Aug; 322(5):462-464. PubMed ID: 31386124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Food and Drug Administration labeling and medication guides: A health outcomes critique.
    Watterson TL
    Res Social Adm Pharm; 2019 Sep; 15(9):1191-1192. PubMed ID: 31003764
    [No Abstract]   [Full Text] [Related]  

  • 29. Prescribing Opioids Safely: How to Facilitate Difficult Patient Conversations.
    Lev R
    Mich Med; 2017 Mar; 116(2):14-15. PubMed ID: 30376253
    [No Abstract]   [Full Text] [Related]  

  • 30. Rethinking opioid prescribing to protect patient safety and public health.
    Alexander GC; Kruszewski SP; Webster DW
    JAMA; 2012 Nov; 308(18):1865-6. PubMed ID: 23150006
    [No Abstract]   [Full Text] [Related]  

  • 31. Trends in Concurrent Opioid and Benzodiazepine Prescriptions in the United States, 2016 to 2019.
    Zhang K; Strahan AE; Guy GP; Larochelle MR
    Ann Intern Med; 2022 Jul; 175(7):1051-1053. PubMed ID: 35667064
    [No Abstract]   [Full Text] [Related]  

  • 32. THE OPIOID EPIDEMIC: MICHIGAN DOCTORS SEEKING SOLUTIONS.
    Mich Med; 2017 Mar; 116(2):16-19. PubMed ID: 30376254
    [No Abstract]   [Full Text] [Related]  

  • 33. Problems with Prescribing Opioids? Read This!
    Herndon M; Mullen J; Splinter GL
    J Okla State Med Assoc; 2016 Jan; 109(1):19-20. PubMed ID: 27027145
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of Opioid Prescribing Patterns in the United States and Japan: Primary Care Physicians' Attitudes and Perceptions.
    Onishi E; Kobayashi T; Dexter E; Marino M; Maeno T; Deyo RA
    J Am Board Fam Med; 2017; 30(2):248-254. PubMed ID: 28379832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDA tightens indications for using long-acting and extended-release opioids to treat chronic pain.
    Kuehn BM
    JAMA; 2013 Oct; 310(15):1547-8. PubMed ID: 24129447
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
    Cowart K; Worley M; Rouby NE; Sando K
    Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681
    [No Abstract]   [Full Text] [Related]  

  • 37. Methadone overdose deaths rise with increased prescribing for pain.
    Kuehn BM
    JAMA; 2012 Aug; 308(8):749-50. PubMed ID: 22910739
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA opioid safety plan promotes patient, physician education to prevent abuse.
    Kuehn BM
    JAMA; 2010 Aug; 304(8):845. PubMed ID: 20736462
    [No Abstract]   [Full Text] [Related]  

  • 39. A recent history of opioid use in the US: Three decades of change.
    Dayer LE; Painter JT; McCain K; King J; Cullen J; Foster HR
    Subst Use Misuse; 2019; 54(2):331-339. PubMed ID: 30572776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. It's Time to Adopt Electronic Prescriptions for Opioids.
    Gawande AA
    Ann Surg; 2017 Apr; 265(4):693-694. PubMed ID: 28067675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.